Date
of Report (Date of earliest event reported)
|
|
March
15, 2007
|
|
|
Progenics
Pharmaceuticals, Inc.
|
(Exact
name of registrant as specified in its
charter)
|
Delaware
|
|
000-23143
|
|
13-3379479
|
|
(State
or other jurisdiction
of
incorporation)
|
|
(Commission
File
Number)
|
|
(IRS
Employer
Identification
No.)
|
|
777
Old Saw Mill River Road, Tarrytown, New York
|
10591
|
|
(Address
of principal executive offices)
|
(Zip Code)
|
|
Registrant's
telephone number, including area code
|
(914)
789-2800
|
|
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR
230.425)
|
|
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR
240.14d-2(b))
|
|
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR
240.13e-4(c)
|
Exhibit
No.
|
|
Description
|
|
|
|
|
|
99.1
|
|
Press
Release dated March 15, 2007
|
|
PROGENICS
PHARMACEUTICALS, INC.
|
||
By:
|
/s/
ROBERT
A.
MCKINNEY
|
|
Robert
A. McKinney
|
||
Chief
Financial Officer Senior Vice President, Finance &
Operations
|